Ketoconazole is an azole antimycotic compound that was discovered in 1976 (Janssen Pharmaceuticals) and patented in 1977. It is a racemic mixture of the two enantiomers: levoketoconazole and dextroketoconazole. It is a bioactive small molecule acting as a protein inhibitor, specifically inhibiting CYP3A5 involved in P-450-dependent steroid biosynthesis. The compound has anti-cancer activity.
Ketoconazole is soluble in DMSO, ethanol, chloroform, and methanol.
This product is considered a dangerous good. Quantities above 1 gram may be subject to additional shipping fees.